Neuron Experts
Preclinical CRO running primary neuronal cell assays for neuropharmacology and neurodermatology companies
Highlights
- New on EvolcAdded 2026-11-02
About Neuron Experts
Neuron Experts is a French contract research organisation (CRO) specialised in the study of neuro-active compounds. It uses its own assays based on primary neuronal cell cultures that model neurodegenerative diseases and neuronal impairment-induced skin disorders. Its three service lines are advisory on preclinical drug and molecule development, internal R&D on new cellular models, and customised studies that assess neurotrophic or neuroprotective effects of client molecules.
Its clients are neuropharmacology and neurodermatology companies that commission advisory, R&D and customised study work. The company is a services provider rather than a software or product business.
Neuron Experts was founded in 2008 by Rémy Steinschneider, who is CEO. It is based in Marseille, where it operates a 200 m² laboratory. The company announced INSPiRE, a preclinical CNS solution with Motac Neuroscience and Cynbiose that combines in vitro, in vivo and non-human primate models.
Product: Preclinical CRO services: advisory, in-house R&D on neuronal cell models, and customised neuroprotection/neurotrophic assays using primary neuronal cell cultures.
Jobs at Neuron Experts
Leadership
- Rémy STEINSCHNEIDER · founder of Neuron Experts, CEO and head of neuro-pharmacology departmentSource: company website
- Elodie GRAS LAVIGNE · COO and head of neuro-dermatology departmentSource: company website
More biotech & pharma companies
Nevezyne
Custom recombinant therapeutic protein expression and purification services for biotechnology and pharmaceutical researchersYoung companyNew on EvolcNextpharma
Contract pharmaceutical development, manufacturing and packaging for drug developers and supplement brandsNew on EvolcNG Biotech
Rapid in vitro diagnostic tests for healthcare professionals, patients and global partnersNew on EvolcNicox
Ophthalmic drug developer focused on glaucoma and eye allergy treatments, with products sold in the U.S. and ChinaNew on EvolcNikaia Pharmaceuticals
Develops small-molecule NIK inhibitors for cancer and autoimmune disease treatmentYoung companyNew on EvolcNoraker
Develops and manufactures resorbable biomaterial implants for surgeons treating bone defects and supporting bone regenerationNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Backend
- PHPMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Cookie namedistinctive cookie name
Frontend frameworks
- BootstrapHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Hosting
- ApacheHigh confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Response headerserver
- Response headerserver
- Response headerserver
Privacy & consent
- AxeptioMedium confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Integration code on pageinline script loader
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.